Despite federal cannabis prohibition, an increasing number of states are implementing or considering cannabis legalization. Washington and Oregon were among the first states to legalize, in 2012 and 2014. Jurisdictions in the U.S. and abroad are looking to the early state adopters to identify best practices for state and local policy, and to learn about the impact of cannabis legalization beyond the short-term. In response to state legalization of recreational cannabis, many communities in Washington and Oregon have initiated additional regulatory policies or taxes. Currently, there is no evidence base to predict the effectiveness of such local policy actions for moderating public health or social outcomes that may follow cannabis legalization.
The Aims of the proposed study are to: 1) Monitor and document local-level changes in cannabis policies, prices, and market activities (e.g., density, sales) in Oregon and Washington. 2) Assess how local variation in cannabis policies, prices, and market activities in Oregon and Washington affect cannabis use and related health outcomes beyond the short-term (5-10 years after legalization) among youth, pregnant and parenting women, and adults. 3) Estimate the short-term and longer-term effects of local-level cannabis policies, prices and market activities on the prevalence and frequency of alcohol and tobacco use among youth, pregnant women, new mothers, and all adults, as well as substance use treatment and hospitalizations related to alcohol and opioids in Oregon and Washington. We will address these aims using quasi-experimental methods and geospatial analyses that exploit within-state and across-time variation in cannabis policies, prices, and market activities. We will collect and review local marijuana policies in both states, retailer-level licensing and transaction data, and assess their association with relevant behavioral, public health and social outcomes. We will rely on multiple established public health surveillance and other data reporting systems, which are largely common across both states. Findings from this study will provide policymakers and other stakeholders with strong evidence about the effectiveness of local cannabis policies on public health outcomes.

Public Health Relevance

Our study will contribute to the evidence about effective public policy by local governments within states that have legalized retail cannabis by providing a systematic description of 1) local (i.e., county/city) policies to regulate cannabis and local market environments (e.g., density of retailers and sales activity); 2) the association between local cannabis policies, prices and market activity and health outcomes among youth, pregnant women and adults; and 3) further association with alcohol, tobacco and opioid outcomes among youth, pregnant women and adults.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA039293-05
Application #
10026091
Study Section
Community Influences on Health Behavior Study Section (CIHB)
Program Officer
Kimmel, Heather L
Project Start
2015-09-15
Project End
2024-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Multnomah County Health Department
Department
Type
DUNS #
030784888
City
Portland
State
OR
Country
United States
Zip Code
97204
Fiala, Steven C; Dilley, Julia A; Firth, Caislin L et al. (2018) Exposure to Marijuana Marketing After Legalization of Retail Sales: Oregonians' Experiences, 2015-2016. Am J Public Health 108:120-127
Dilley, Julia A; Hitchcock, Laura; McGroder, Nancy et al. (2017) Community-level policy responses to state marijuana legalization in Washington State. Int J Drug Policy 42:102-108
Smart, Rosanna; Caulkins, Jonathan P; Kilmer, Beau et al. (2017) Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state. Addiction 112:2167-2177
Smart, Rosanna; Caulkins, Jonathan P; Kilmer, Beau et al. (2017) Response to Commentaries: new data sources for understanding cannabis markets. Addiction 112:2180-2181